Chlamydia Infections Market Insights, Treatment, Pipeline Review, H1 2016 by Radiant Insights

Chlamydia Infections Market Treatment, Share,
Symptoms, Pipeline Review, H1 2016 by Radiant
Global Markets Direct's, ‘Chlamydia Infections - Pipeline Review, H1 2016', provides an overview of the
Chlamydia Infections pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chlamydia
Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological
action of the therapeutics, its complete research and development history and latest news and press
releases. Additionally, the report provides an overview of key players involved in therapeutic
development for Chlamydia Infections and features dormant and discontinued projects.
Browse Ongoing Reports @
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic
review following a stringent set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter strategies to gain
competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data.
- The report provides a snapshot of the global therapeutic landscape of Chlamydia Infections
- The report reviews pipeline therapeutics for Chlamydia Infections by companies and
universities/research institutes based on information derived from company and industry-specific
- The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental
- The report reviews key players involved Chlamydia Infections therapeutics and enlists all their major
and minor projects
- The report assesses Chlamydia Infections therapeutics based on drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Chlamydia Infections
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for
Chlamydia Infections
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline
- Devise corrective measures for pipeline projects by understanding Chlamydia Infections pipeline depth
and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline
Browse More Categories @
Table of Content
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Chlamydia Infections Overview 7
Therapeutics Development 8
Pipeline Products for Chlamydia Infections - Overview 8
Pipeline Products for Chlamydia Infections - Comparative Analysis 9
Chlamydia Infections - Therapeutics under Development by Companies 10
Chlamydia Infections - Therapeutics under Investigation by Universities/Institutes 11
Chlamydia Infections - Pipeline Products Glance 12
Late Stage Products 12
Early Stage Products 13
Chlamydia Infections - Products under Development by Companies 14
Chlamydia Infections - Products under Investigation by Universities/Institutes 15
Chlamydia Infections - Companies Involved in Therapeutics Development 16
Abera Bioscience AB 16
Adamis Pharmaceuticals Corporation 17
CEL-SCI Corporation 18
Genocea Biosciences, Inc. 19
Merck & Co., Inc. 20
NanoBio Corporation 21
Prokarium Limited 22
QureTech Bio AB 23
Selecta Biosciences, Inc. 24
SIGA Technologies, Inc. 25
Chlamydia Infections - Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Target 27
Assessment by Mechanism of Action 29
Assessment by Route of Administration 31
Assessment by Molecule Type 33
Drug Profiles 35
Browse Ongoing Reports @
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and individuals procure market
research reports, helping them in the decision making process. We have a comprehensive collection of
reports, covering over 40 key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of ancillary services such
as, research partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Visit our Blog:

Global Markets Direct's, ‘Chlamydia Infections - Pipeline Review, H1 2016', provides an overview of the Chlamydia Infections pipeline landscape. Read More @